ARCHIVES

FDA’s Oncologic Drugs Advisory Committee recommended approval of three drugs for cancer, voted down one.

This article is from The Cancer Letter archive.

Vol. 31 No. 33 | September 16, 2005

Download PDF Visit The Full Archive

Related Articles

Zerhouni Announces Changes To NIH Peer Review.

June 6, 2008

Clinical Trials Approved By NCI CTEP During July

August 30, 2002

Natcher: Multiple Year Funding Would Not be Approved If Presented As Request For Reprogramming

March 22, 1985

Also Kevin Cullen named director, Univ. of Maryland Greenebaum Cancer Center.

November 28, 2003

Richard Wood, ICRF, Accepts Appointment At Pittsburgh.

March 2, 2001

In Multi-Site Phase I Studies, No Investigator Sees All Toxicities

March 26, 2010